Bellicum Announces Update on Clinical Hold of U.S. BPX-501 Studies
Feb 23, 2018 12:00 pm UTC| Business
HOUSTON, Feb. 23, 2018 -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced it has...
Hill International Wins Extension to Continue Support of Port of Long Beach Expansion
Feb 23, 2018 12:00 pm UTC| Business
PHILADELPHIA and IRVINE, Calif., Feb. 23, 2018 -- Hill International (NYSE:HIL), the global leader in managing construction risk, announced it will continue serving the Port of Long Beach on the 10-year, $1.49 billion...
Potbelly Corporation Reports Results for Fourth Fiscal Quarter and Full Fiscal Year 2017
Feb 23, 2018 12:00 pm UTC| Business
CHICAGO, Feb. 23, 2018 -- Potbelly Corporation (NASDAQ:PBPB) today reported financial results for the fourth quarter and full fiscal year ended December 31, 2017. Key highlights for the fourteen weeks ended December...
Summit Therapeutics to Participate in 2018 BTIG Healthcare Conference
Feb 23, 2018 12:00 pm UTC| Business
OXFORD, United Kingdom, Feb. 23, 2018 -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, announces that...
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
Feb 23, 2018 12:00 pm UTC| Business
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Feb. 23, 2018 -- Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of...
Surgery Partners Names Angela Justice Chief Human Resource Officer
Feb 23, 2018 12:00 pm UTC| Business
Newly created position highlights the importance of talent development to the Company’s long-term growth strategy Executive with extensive experience in building teams, effecting cultural change and driving business...
Feb 23, 2018 12:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 23, 2018 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year...